A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

Clinical trial NCT05053165 · COMPLETED

Trial details

NCT number: NCT05053165
Sponsor: LISCure Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis Non-Alcoholic Steatohepatitis

Start date: 2022-01-04
Primary completion: 2022-04-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.